MedTrace Logo

Multicenter, Prospective, Non-interventional, Observational Study to Confirm the Long-term Efficacy and Safety of Rosuampin Tab. in Patients With Hypertension and Hypercholesterolemia

NCT06293261 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 5047

Last updated 2025-01-22

No results posted yet for this study

Summary

This study is to confirm the long-term efficacy and safety of Rosuampin Tab. in patients with hypertension and hypercholesterolemia

Conditions

Interventions

DRUG

Rosuampin 5/5mg, 10/5mg, 20/5mg, 10/10mg

Experimental only, not included active and placebo comparator

Sponsors & Collaborators

  • Yuhan Corporation

    lead INDUSTRY

Principal Investigators

  • Moohyun Kim · Dong-A University Hospital

Eligibility

Min Age
19 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-06-27
Primary Completion
2024-03-31
Completion
2024-03-31

Countries

  • South Korea

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06293261 on ClinicalTrials.gov